AI assistant
Sending…
CONMED Corp — Director's Dealing 2022
Jul 7, 2022
31971_dirs_2022-07-07_3bc504df-eb82-42d0-954b-9d80bb71b628.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2022-06-30
Reporting Person: Lalomia Brent (Vice President QA and RA)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-06-30 | Common Stock | L | 0.737 | $97.693 | Acquired | 678.737 | Direct |
Footnotes
F1: The acquisition was pursuant to a written plan.
More from CONMED Corp
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 18